Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Acta Pharmaceutica Sinica
>
2010
>
45
>
2
Volume:
45
Issue:
2
1. LC-MS/MS method for simultaneous quantification of lopinavir and ritonavir in human plasma.
Page:279—282
2. Quantitative structure-cytotoxicity relationship of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives.
Page:274—278
3. Antiviral activities of cycloheximide and its derivatives.
Page:268—273
4. Design, synthesis of quinolinone acid-containing compounds with anti-HIV integrase activity.
Page:263—267
5. Establishment and application of a screening anti-HIV-1 drug model targeted nuclear trafficking of virus RNA.
Page:257—262
6. In vitro pharmacodynamics study of an anti-HIV Chinese herbal formulation.
Page:253—256
7. Establishment and application of a high-throughput screening assay for premature activation of HIV-1 precursors.
Page:247—252
8. In vitro selection and identification of HIV strain which is resistance to two new HIV-1 nonnucleoside reverse transcriptase inhibitors.
Page:241—246
9. Effective components against HIV-1 replicative enzymes isolated from plants.
Page:235—240
10. Inhibition of the replication of HIV-1 by norcantharidin in vitro.
Page:224—227
11. Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds.
Page:215—223
12. The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors.
Page:205—214
13. The newest developments in anti-HIV-1 drugs.
Page:194—204
14. The current progress in the development of HIV-1 fusion inhibitors.
Page:184—193
15. Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Page:177—183
16. Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008.
Page:154—164
17. Advances in the study of anti-HIV natural compounds derived from traditional Chinese medicines.
Page:141—153
18. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
Page:228—234
19. The development of anti-HIV-1 drugs.
Page:165—176
20. HIV entry inhibitors: progress in development and application.
Page:131—140
21. The newest developments in anti-HIV-1 drugs.
Page:194—204
22. The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors.
Page:205—14
23. Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds.
Page:215—23
24. Advances in the study of anti-HIV natural compounds derived from traditional Chinese medicines.
Page:141—53
25. Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008.
Page:154—64
26. Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Page:177—83
27. The current progress in the development of HIV-1 fusion inhibitors.
Page:184—93
28. Inhibition of the replication of HIV-1 by norcantharidin in vitro.
Page:224—7
29. Effective components against HIV-1 replicative enzymes isolated from plants.
Page:235—40
30. In vitro selection and identification of HIV strain which is resistance to two new HIV-1 nonnucleoside reverse transcriptase inhibitors.
Page:241—6
31. Establishment and application of a high-throughput screening assay for premature activation of HIV-1 precursors.
Page:247—52
32. In vitro pharmacodynamics study of an anti-HIV Chinese herbal formulation.
Page:253—6
33. Establishment and application of a screening anti-HIV-1 drug model targeted nuclear trafficking of virus RNA.
Page:257—62
34. Design, synthesis of quinolinone acid-containing compounds with anti-HIV integrase activity.
Page:263—7
35. Antiviral activities of cycloheximide and its derivatives.
Page:268—73
36. Quantitative structure-cytotoxicity relationship of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives.
Page:274—8
37. LC-MS/MS method for simultaneous quantification of lopinavir and ritonavir in human plasma.
Page:279—82
38. HIV entry inhibitors: progress in development and application.
Page:131—40
39. The development of anti-HIV-1 drugs.
Page:165—76
40. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
Page:228—34
